Skin Signs of Infective Endocarditis
The skin signs of infective endocarditis (IE) are a set of highly valuable clinical clues. They act as a window that lets dermatologists and internists recognize, early on, a life-threatening infection of the heart's inner lining and valves. Common causative organisms include Staphylococcus aureus (typical of acute IE on native valves and in people who inject drugs), Streptococcus viridans (subacute IE), Enterococcus faecalis and the HACEK group of bacteria. Bacterial vegetations on the valve surfaces shed bacteria and embolic fragments into the bloodstream. The resulting skin lesions are not simply a by-product of systemic infection; they arise through two quite different core mechanisms – septic microembolism and immune complex-mediated vasculitis. Telling Osler nodes, Janeway lesions, splinter hemorrhages and petechial or purpuric rashes apart supports the diagnosis under the modified Duke criteria. At Haute-Derma, we use digital dermoscopy, perform urgent biopsies of small-vessel lesions when indicated, apply the Duke criteria, and coordinate the start of high-dose IV antibiotics alongside full cardiology input.
How the skin lesions develop:
- Septic microemboli and dermal microabscesses:
- Fragments break off the valve vegetations, travel in the bloodstream and lodge in the papillary capillaries or in small arteries of the dermis and subcutis at the extremities (palms, soles, nail beds).
- Bacteria within these emboli multiply on the spot, release tissue-destroying toxins and attract neutrophils. This produces microabscesses, central necrosis and ruptured vessels that bleed – the mechanism behind Janeway lesions and splinter hemorrhages.
- Immune complex deposition and leukocytoclastic vasculitis:
- In longstanding subacute IE, the body mounts a humoral immune response, producing large amounts of IgG and IgM antibodies that bind bacterial antigens to form circulating immune complexes (CICs).
- CICs settle in the walls of small arteries and in glomus bodies – arteriovenous shunts rich in sensory nerve fibers – in the subcutis of the fingertips and toes. There they activate complement (C3a, C5a) and draw in neutrophils that release protein-digesting enzymes, causing leukocytoclastic vasculitis, fibrinoid necrosis of the vessel wall and intense pain. This is how Osler nodes form.
- Capillary fragility and petechiae: Circulating toxins, together with immune complex-driven inflammation of small vessels, weaken the junctions between endothelial cells in the superficial dermal capillaries. Small numbers of red blood cells leak out, producing scattered pinpoint hemorrhages (petechiae) on the conjunctiva, the inside of the mouth and the skin.
Skin Signs of Infective Endocarditis
| Skin Lesion / Sign | Typical Clinical Appearance | Mechanism and Clinical Significance |
|---|---|---|
| Osler nodes | Slightly raised red nodules, very tender to pressure, in the pads of the fingers and toes; last 1–3 days, then fade. | Immune complex deposition causing vasculitis; typical of subacute IE (S. viridans); a Duke minor criterion (immunologic phenomenon). |
| Janeway lesions | Flat red or hemorrhagic macules or patches on the palms and soles, completely painless. | Septic microemboli causing necrotizing microabscesses; typical of acute IE (S. aureus); a Duke minor criterion (vascular phenomenon). |
| Splinter hemorrhages | Thin dark red or brown streaks running lengthwise under the nail, concentrated in the proximal third near the nail base. | Septic emboli or ruptured nail-bed capillaries; most significant when several nails are affected at once. |
| Petechiae and purpura | Tiny (1–2 mm) red-purple dots that do not blanch with pressure, on the conjunctiva, palate, chest and forearms. | Capillary leakage from toxins or small-vessel vasculitis; the most common early skin sign (20–40% of IE patients). |
Telling the Skin Lesions of Infective Endocarditis Apart
| Janeway Lesions | Osler Nodes | Splinter Hemorrhages |
|---|---|---|
| Completely NON-tender | VERY tender to touch or pressure | Usually painless (unless there is also nail trauma) |
| Palms, soles, thenar and hypothenar eminences | Pads (pulp) of the fingers and toes | Fingernail and toenail beds (under the nail plate) |
| Septic emboli | Immune complexes | Septic emboli or capillary rupture |
| Microabscesses and endothelial necrosis, with bacteria present | Leukocytoclastic vasculitis and fibrinoid necrosis, with NO bacteria | Subungual hemorrhage and capillary microthrombi |
| Acute IE (Staphylococcus aureus) | Subacute IE (Streptococcus viridans) | Both acute and subacute IE |
Our Approach
At Haute-Derma, patients with skin findings suggestive of infective endocarditis go through a structured, systematic workup:
- Digital dermoscopy and diascopy:
- Dermoscopy shows the vascular pattern: Janeway lesions appear as a dark red central hemorrhage with a pale red rim around the capillaries, while Osler nodes show a red area with loss of visible vascular structures because of deep inflammatory swelling.
- Diascopy (pressing with a glass slide): confirms that petechiae and Janeway lesions do not blanch, showing that they are due to blood leakage or hemorrhagic necrosis.
- Applying the modified Duke criteria: We record the skin-related minor criteria: Janeway lesions and splinter hemorrhages (classed as vascular phenomena), and Osler nodes and retinal Roth spots (classed as immunologic phenomena).
- Systemic workup and emergency referral:
- Three sets of blood cultures are drawn from separate venipuncture sites, at least 30–60 minutes apart, before any antibiotics are given.
- Inflammatory and immune markers are measured: rheumatoid factor (RF, positive because of immune complexes), erythrocyte sedimentation rate (ESR), CRP and complement (low C3, C4).
- The patient is urgently referred for transthoracic (TTE) or transesophageal (TEE) echocardiography to look for valve vegetations.
Treatment at Haute-Derma
Because the skin signs of IE reflect a deep-seated cardiovascular infection, our treatment focuses on controlling the systemic infection and providing supportive care for the skin lesions:
- High-dose IV antibiotics targeted to the organism:
- Empiric therapy while awaiting blood cultures (native-valve IE): ampicillin/sulbactam (12 g/day IV in 4 divided doses) plus gentamicin; or vancomycin (15–20 mg/kg IV every 8–12 hours) plus ceftriaxone (2 g/day IV).
- Methicillin-sensitive S. aureus (MSSA) IE: high-dose IV cloxacillin or cefazolin for 4–6 weeks.
- Methicillin-resistant S. aureus (MRSA) IE: vancomycin or daptomycin (10 mg/kg/day).
- Local skin care – and no direct invasive procedures:
- Osler nodes and Janeway lesions must never be incised, aspirated or treated with lasers or other mechanical methods. They are not primary skin abscesses and will resolve on their own once systemic antibiotics clear the bacteria and immune complexes.
- Gently clean the skin surface with chlorhexidine 2% and keep the fingers and toes clean to prevent secondary infection.
- Tracking the skin lesions to gauge treatment response: Regression of Osler nodes (usually within 2–5 days of effective antibiotics) and of Janeway lesions serves as a supporting clinical sign that the bloodstream infection is coming under control.